Research background · Updated November 1, 2026
Dulaglutide Research: Publications, Study Types and Background
Short answer
Dulaglutide. As of November 1, 2026, PubMed indexes 1,330 records matching Dulaglutide, the earliest from 2006; 696 were published in 2021–2025 and 366 are reviews. ClinicalTrials.gov lists 150 registered studies matching the compound.
- PubMed records
- 1,330
- Earliest record
- 2006
- Published 2021–2025
- 696
- Reviews
- 366
- Animal-only studies
- 49
- Registered studies
- 150
Publications per year, 2006–2025
1,149 records in 2016–2025 against 73 in 2006–2015; the busiest year was 2025, with 232.
See the numbers
| Year | PubMed records |
|---|---|
| 2006 | 1 |
| 2007 | 0 |
| 2008 | 0 |
| 2009 | 0 |
| 2010 | 1 |
| 2011 | 0 |
| 2012 | 6 |
| 2013 | 2 |
| 2014 | 19 |
| 2015 | 44 |
| 2016 | 58 |
| 2017 | 51 |
| 2018 | 77 |
| 2019 | 93 |
| 2020 | 110 |
| 2021 | 106 |
| 2022 | 112 |
| 2023 | 137 |
| 2024 | 173 |
| 2025 | 232 |
Study types
| All PubMed records | 1,330 |
|---|---|
| Reviews | 36628% |
| Animal studies (no human subjects indexed) | 494% |
| Indexed as clinical trials | 15812% |
| Registered on ClinicalTrials.gov | 150 |
Categories overlap and follow PubMed’s own indexing; recent records may not be indexed yet.
Primary research directions
What 2 of the most-cited and most recent Dulaglutide papers report, in their own authors’ terms. Each line links the paper it came from.
Long-acting GLP-1 receptor activation
This review of GLP-1 receptor agonists says newer agents overcame the short half-life that limited the first ones, and lists dulaglutide among the once-weekly injectable agents alongside exenatide once weekly, albiglutide and semaglutide.
ReviewNauck MA 2021Molecular metabolismPMID 33068776
Cardiovascular outcomes
In 9,901 adults with type 2 diabetes followed for a median 5.4 years, the composite of non-fatal heart attack, non-fatal stroke or cardiovascular death occurred in 12.0% with dulaglutide against 13.4% with placebo, and gastrointestinal adverse events were reported by 47.4% against 34.1%.
HumansGerstein HC 2019Lancet (London, England)PMID 31189511
Most-studied topics
The Medical Subject Headings (MeSH) PubMed indexers most often marked as a main topic, across 400 of the 1,330 records. They describe what the literature is about, not what Dulaglutide does.
- Diabetes Mellitus, Type 2238 papers
- Glucagon-Like Peptides189 papers
- Immunoglobulin Fc Fragments185 papers
- Recombinant Fusion Proteins179 papers
- Hypoglycemic Agents163 papers
- Glucagon-Like Peptide-1 Receptor Agonists32 papers
- Liraglutide23 papers
- Cardiovascular Diseases19 papers
Key papers
Earliest indexed record
Author not listed (2006). .
PMID 30000038Most-cited paper · 673 citations
Frias JP (2018). Lancet (London, England).
PMID 30293770Most-cited #2 · 646 citations
Pratley RE (2018). The lancet. Diabetes & endocrinology.
PMID 29397376Most-cited #3 · 541 citations
Tuttle KR (2018). The lancet. Diabetes & endocrinology.
PMID 29910024
Citation counts from NIH iCite, among the 400 records sampled. Titles are left out; open each record on PubMed to read it.
Identity
| Identity data | On request |
|---|
Identity data from PubChem, retrieved November 1, 2026, on the Dulaglutide page.
How these numbers were counted
- PubMed search, run November 1, 2026:
dulaglutide[tiab]re-run it. Study types add PubMed’s own filters (review, clinical trial, animals not humans). - Topics: MeSH major-topic headings counted across up to 400 of the matching records; headings for study set-up (species, sex, age) are left out.
- Citations: NIH iCite citation counts for the same records.
- ClinicalTrials.gov search:
dulaglutidere-run it. Any phase, any status.
This page reports what has been published and what papers say they found, with each source linked. It gives no dosing or usage information, and nothing here is a reason to use Dulaglutide outside a laboratory.
Wholesale supply
Dulaglutide, sourced to order for research.
Not held in the listed catalog. Tell us the vial size and the number of vials and we come back with availability, documentation and pricing in writing.
Dulaglutide research questions
How much research has been published on Dulaglutide?
PubMed indexes 1,330 records matching Dulaglutide (searched November 1, 2026), including 366 reviews and 158 records indexed as clinical trials. 696 were published in the five years 2021–2025.
When was Dulaglutide first described in the literature?
The earliest PubMed record matching Dulaglutide is from 2006 (first author not listed, , PMID 30000038).
What topics does the Dulaglutide literature cover?
The subject headings PubMed indexers most often marked as a main topic of Dulaglutide papers are Diabetes Mellitus, Type 2, Glucagon-Like Peptides, Immunoglobulin Fc Fragments, Recombinant Fusion Proteins. These describe what the literature is about. Findings from individual papers, with their sources, are summarized on this page.
Is Dulaglutide sold for human use?
No. Vanta Foundry supplies it for laboratory research use only. Not for human or veterinary use, and not a drug, food, cosmetic or dietary supplement.
Where can I buy Dulaglutide wholesale for research?
We source Dulaglutide to order rather than stock it. Tell us the vial size and number of vials on WhatsApp or by email and the quote confirms availability, documentation and pricing.
Research materials supplied by Vanta Foundry are for laboratory research use only. They are not for human or veterinary use and are not drugs, foods, cosmetics or dietary supplements. Websites and payment processing are business services for research-supply brands.
All compounds: research peptide publication statistics.